30 Nov UW launches improved payment system for research participants
The University of Wisconsin–Madison is rolling out a new system to make payment to research participants easier and more efficient....
News
30 Nov UW–Madison remains 8th in research ranking, surpasses $1.5 billion in research expenditures
The University of Wisconsin–Madison, for the first time, has topped $1.5 billion in research expenditures, according to the National Science Foundation. With this accomplishment, UW–Madison is ranked 8th among the nearly 900 public and private universities surveyed by NSF....
29 Nov Lauren McLester-Davis becomes UW’s first director of Indigenous science advocacy
Posted at 15:46h
in Health Equity, Clinical Research, UW–Madison, UW Health, Diversity, UW SMPH, Clinical Trials
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy....
26 Nov This lifesaving treatment was designed for one. Could it be the future of medical care?
Susannah is at the vanguard of a new movement in medicine: therapy so specialized it is designed for just a few patients, or even a single one. Such bespoke therapies are possible because of advances in medicine including gene therapy, the messenger RNA approach used...
21 Nov Invisible in the data: Broad ‘Asian American’ category obscures health disparities
They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with...
21 Nov Never Fear, Assertiveness is an Indispensable Soft Skill for Clinical Researchers
The duties of trial team members, other site staff, and their vendors are performed so “behind the scenes” compared to the rest of the institutions’ activities, it can be a struggle to get their priorities and contributions noticed properly by leadership. As a result, study...
20 Nov Researchers return to Alzheimer’s vaccines, buoyed by recent drug success
Clinical trials are underway or completed for at least seven Alzheimer’s vaccines designed to harness the immune system to rid the brain of the disease-related proteins beta amyloid or tau, a review of the U.S. government’s ClinicalTrials.gov database found. More are on the way....
20 Nov Ingestible pill that monitors vitals yields positive results in human trial
An ingestible pill that monitors vital signs from inside the body has produced positive results from a first-in-human study. The data, published on 17 November in the journal Device, demonstrates that the mini sensor could replace intrusive, wearable sensors in sleep studies....
20 Nov Decentralized Clinical Trials: Being Audit Ready and Avoiding Pitfalls
As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams....
17 Nov Scientists produce human norepinephrine neurons from stem cells, with significant implications for researching diseases like Alzheimer’s and Parkinson’s
Researchers at the University of Wisconsin–Madison have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer’s and Parkinson’s diseases and used the discovery to grow the neurons from stem cells for the...